Amigraine ADCO - 30 Tablets

Symptomatic treatment and prevention of migraine attacks and other types of headaches.

Histamine cephalalgia and occipital neuralgia.

Tradename: Amigrain ASDO

Amigraine ADCO

Composition: Each tablet, p/ o contains:

Analgin — 300mg.

Caffeine — 100mg

Ergotamine tartarate — Img

Auxiliary components: talc, magnesium stearate, starch.

Properties: Ergotamine tartarate is the most effective substance for relieving migraine pain. Its effect is further enhanced by caffeine and analgin, and has an analgesic effect that helps relieve pain attacks.

Indications: symptomatic treatment and prevention of migraine attacks and other types of headac Histamine cephalalgia and occipital neuralgi

Mode of application: to prevent an acute attack, take 1 to 4 tablets per day. One dose (1 to 2 tablets) is sufficient in most cases to prevent an attack (or as directed by a physician).

Contraindications: peripheral vascular disease, ischemic heart disease, impaired renal or liver function, as well as during pregnancy.

Side effects: increased risk of agranulocytosis and shock. Changes in heart rate, nausea, vomiting, leg weakness, muscle pain in the limbs, numbness and tingling in the fingers and toes, localized edema, itching.

Drug interaction: Taking ergotamine and macrolide antibiotics such as erythromycin leads to ergotism (poisoning of the human body by the alkalo• of the ergot fungus). Ergotamine should no given to patients receiving sumatriptan until 6 hours have elapsed after stopping the drug.

Precautionary measures: Addiction can develop imperceptibly if ergotamine tartrate is used more than 2 days a week, even if the general daily or weekly dosage guidelines are followed.

Hypersensitivity and leukocyte abnormalities may occur during treatment with this drug. If the patient’s well-being is disturbed during long-term treatment, the leukocyte count should be checked and, in case of a decrease in the granulocyte content, the drug should be discontinued. The drug contains analgin, which can cause agranulocytosis. The drug should not be administered to children.

Pregnancy and lactation: should not be used by pregnant and lactating mothers, as these substances are excreted in breast milk.

Storage: Store at a temperature not exceeding 30C in a dry place out of the reach of children.

Packaging: The cardboard box contain 30 blister of 10 tables